Search Results
You are looking at 1 - 4 of 4 items for
- Author: Saleela M Ruwanpura x
- Refine by access: All content x
Search for other papers by Saleela M Ruwanpura in
Google Scholar
PubMed
Search for other papers by Robert I McLachlan in
Google Scholar
PubMed
Search for other papers by Sarah J Meachem in
Google Scholar
PubMed
Over the past five decades, intense research using various animal models, innovative technologies notably genetically modified mice and wider use of stereological methods, unique agents to modulate hormones, genomic and proteomic techniques, have identified the cellular sites of spermatogenesis, that are regulated by FSH and testosterone. It has been established that testosterone is essential for spermatogenesis, and also FSH plays a valuable role. Therefore understanding the basic mechanisms by which hormones govern germ cell progression are important steps towards improved understating of fertility regulation in health diseases.
Prince Henry's Institute of Medical Research, Department of Obstetrics and Gynaecology, Monash Institute of Medical Research and ARC Centre of Excellence in Biotechnology and Development, Clayton, Victoria 3168, Australia
Search for other papers by Saleela M Ruwanpura in
Google Scholar
PubMed
Prince Henry's Institute of Medical Research, Department of Obstetrics and Gynaecology, Monash Institute of Medical Research and ARC Centre of Excellence in Biotechnology and Development, Clayton, Victoria 3168, Australia
Search for other papers by Robert I McLachlan in
Google Scholar
PubMed
Search for other papers by Peter G Stanton in
Google Scholar
PubMed
Search for other papers by Kate L Loveland in
Google Scholar
PubMed
Search for other papers by Sarah J Meachem in
Google Scholar
PubMed
FSH is a key regulator of testis function, required for the establishment of full complements of Sertoli and germ cells during postnatal testis development and for the maintenance of spermatogenesis in the adult. FSH plays an important role in germ cell survival rather than proliferation, in the window between 14 and 18 days of testicular development, which coincides with the cessation of Sertoli cell proliferation and the onset of germ cell meiosis during the first wave of spermatogenesis. This study aimed to identify the pathway(s) of apoptosis regulated by changes in FSH levels in 14 - to 18-day-old rats, using a model of in vivo FSH suppression by passive immunoneutralization with a rat anti-FSH antibody. Apoptotic pathways were identified by immunohistochemistry using pathway-specific proteins as markers of the intrinsic (activated caspase 9) and extrinsic (activated caspase 8) pathways, followed by quantification of cell numbers using stereological techniques. In addition, RT-PCR was used to assess the expression of pathway-specific genes. We previously reported a 2.5-fold increase in spermatogonial apoptosis in these samples after 4 days of FSH suppression, and now show that this increase correlates with a 9.8-fold (P<0.001) increase in the frequency of caspase 9-positive spermatogonia in the absence of caspase 8 immunoreactivity. By contrast, spermatocytes exhibited both increased caspase 9 (7.5-fold; P<0.001) and caspase 8 (5.7 fold; P<0.001) immunoreactivities after 4 days of FSH suppression. No significant change in the transcription levels of candidate genes required for either pathway was detected. This study demonstrates that, in the seminiferous tubules, FSH suppression induces spermatogonial apoptosis predominantly via the intrinsic pathway, while spermatocyte apoptosis occurs via both the intrinsic and extrinsic pathways.
Institute of Reproductive Medicine, University of Münster, Münster, Germany
University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
Search for other papers by Sarah J Meachem in
Google Scholar
PubMed
Institute of Reproductive Medicine, University of Münster, Münster, Germany
University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
Search for other papers by Stefan Schlatt in
Google Scholar
PubMed
Institute of Reproductive Medicine, University of Münster, Münster, Germany
University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
Search for other papers by Saleela M Ruwanpura in
Google Scholar
PubMed
Institute of Reproductive Medicine, University of Münster, Münster, Germany
University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
Search for other papers by Peter G Stanton in
Google Scholar
PubMed
The roles of testosterone (T) and its metabolites on hamster spermatogenesis are poorly defined. This study assessed the effects of T, dihydrotestosterone (DHT) and oestradiol (E) on the re-initiation of spermatogenesis in the adult Djungarian hamster. Hamsters raised under long photoperiods (LD, 16 h light:8 h darkness) were exposed to short photoperiods (SD, 8 h light:16 h darkness) for 11 weeks to suppress gonadotrophins. Groups of eight animals then received T, DHT and E for 5 weeks. Cell numbers were determined using the optical disector (sic). The number of Sertoli cells was suppressed in SD controls to 48% (P < 0.001) of LD control and restored either fully or partially by exogenous DHTand E (2.6- and 1.8-fold above SD levels) respectively, corresponding with a twofold elevation of serum FSH. The number of germ cells in SD animals was reduced (all P < 0.001) to levels reported. The number of type A spermatogonia increased in line with the rise in Sertoli cell number, by 2.6-fold (P < 0.01) and 1.8-fold (NS) above SD controls after DHT and E treatments respectively. DHT increased the number of type B spermatogonia/preleptotene spermatocytes, leptotene/zygotene and pachytene spermatocytes by 3.5-, 5.7- and 21-fold above SD (all P < 0.01) respectively, compared with a 2.2-fold (P < 0.01), 2.4-fold (not significant, NS) and 6-fold (NS) in E-treated animals respectively. Exogenous T had little effect on cell numbers or serum FSH compared with SD controls. Spermatids were rarely observed after steroid treatment. We believe this study suggests that steroids can regulate the re-initiation of early spermatogenic cells via a mechanism which includes FSH.
Monash Institute for Medical Research, Monash University, Clayton, Victoria, 3168, Australia
Center for Reproductive Biology, School of Molecular Biosciences, Washington State University, Pullman, Washington, 99164, USA
The Australian Research Council Centre of Excellence in Biotechnology and Development
Search for other papers by Sarah J Meachem in
Google Scholar
PubMed
Monash Institute for Medical Research, Monash University, Clayton, Victoria, 3168, Australia
Center for Reproductive Biology, School of Molecular Biosciences, Washington State University, Pullman, Washington, 99164, USA
The Australian Research Council Centre of Excellence in Biotechnology and Development
Search for other papers by Saleela M Ruwanpura in
Google Scholar
PubMed
Monash Institute for Medical Research, Monash University, Clayton, Victoria, 3168, Australia
Center for Reproductive Biology, School of Molecular Biosciences, Washington State University, Pullman, Washington, 99164, USA
The Australian Research Council Centre of Excellence in Biotechnology and Development
Search for other papers by Jessica Ziolkowski in
Google Scholar
PubMed
Monash Institute for Medical Research, Monash University, Clayton, Victoria, 3168, Australia
Center for Reproductive Biology, School of Molecular Biosciences, Washington State University, Pullman, Washington, 99164, USA
The Australian Research Council Centre of Excellence in Biotechnology and Development
Search for other papers by Jacquelyn M Ague in
Google Scholar
PubMed
Monash Institute for Medical Research, Monash University, Clayton, Victoria, 3168, Australia
Center for Reproductive Biology, School of Molecular Biosciences, Washington State University, Pullman, Washington, 99164, USA
The Australian Research Council Centre of Excellence in Biotechnology and Development
Search for other papers by Michael K Skinner in
Google Scholar
PubMed
Monash Institute for Medical Research, Monash University, Clayton, Victoria, 3168, Australia
Center for Reproductive Biology, School of Molecular Biosciences, Washington State University, Pullman, Washington, 99164, USA
The Australian Research Council Centre of Excellence in Biotechnology and Development
Search for other papers by Kate L Loveland in
Google Scholar
PubMed
The critical influence of follicle stimulating hormone (FSH) on male fertility relates both to its impact on Sertoli cell proliferation in perinatal life and to its influence on the synthesis of Sertoli cell-derived products essential for germ cell survival and function in the developing adult testis. The nature and timing of this shift of germ cells to their reliance on specific Sertoli cell-derived products are not defined. Based on existing data, it is apparent that the dominant function of FSH shifts between 9 and 18 day postpartum (dpp) during the first wave of spermatogenesis from driving Sertoli cell proliferation to support germ cells. To enable comprehensive analysis of the impact of acute in vivo FSH suppression on Sertoli and germ cell development, FSH was selectively suppressed in Sprague–Dawley rats by passive immunisation for 2 days and/or 4 days prior to testis collection at 3, 9 and 18 dpp. The 3 dpp samples displayed no measurable changes, while 4 days of FSH suppression decreased Sertoli cell proliferation and numbers in 9 dpp, but not 18 dpp, animals. In contrast, germ cell numbers were unaffected at 9 dpp but decreased at 18 dpp following FSH suppression, with a corresponding increase in germ cell apoptosis measured at 18 dpp. Sixty transcripts were measured as changed at 18 dpp in response to 4 days of FSH suppression, as assessed using Affymetrix microarrays. Some of these are known as Sertoli cell-derived FSH-responsive genes (e.g. StAR, cathepsin L, insulin-like growth factor binding protein-3), while others encode proteins involved in cell cycle and survival regulation (e.g. cyclin D1, scavenger receptor class B 1). These data demonstrate that FSH differentially affects Sertoli and germ cells in an age-dependent manner in vivo, promoting Sertoli cell mitosis at day 9, and supporting germ cell viability at day 18. This model has enabled identification of candidate genes that contribute to the FSH-mediated pathway by which Sertoli cells support germ cells.